遗传

• 综述 •    

逆转录转座子LINE-1肿瘤发生中的“双刃剑”

田璐,刘茜,岑山,李晓宇   

  1. 中国医学科学院&北京协和医学院,医药生物技术研究所免疫生物学室,北京 100050
  • 收稿日期:2025-11-05 修回日期:2026-01-16 发布日期:2026-02-09
  • 基金资助:

    国家自然科学基金项目(编号:31870164),中国医学科学院医学与健康科技创新工程基金项目(编号:2021-I2M-1-043)和国家重点研发计划项目(编号:2023YFC2306701)资助[Supported by the National Natural Science Foundation of China Grant (No. 31870164), the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (No. 2021-I2M-1-043), and the National Key R&D Program of China (No. 2023YFC2306701)]

The retrotransposon LINE-1: a double-edged sword in tumorigenesis

Lu Tian,Qian Liu,Shan Cen,Xiaoyu Li   

  1. Department of Immunology, Institute of Medicinal Biotechnology, Chinese academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
  • Received:2025-11-05 Revised:2026-01-16 Online:2026-02-09

摘要: 转座子又称跳跃基因,是一段能够在染色体内或不同染色体之间改变自身位置的DNA序列。长散在核元件-1long interspersed element 1LINE-1)作为人类基因组中唯一具有自主逆转座活性的转座子,其动态调控对维持基因组稳定性具有重要的意义。在正常生理状态下,宿主通过表观遗传等机制使LINE-1处于沉默状态,但当这种精密调控被打破时,LINE-1异常激活介导的插入突变会引发基因组不稳定,进而诱发多种遗传性疾病和恶性肿瘤。近年来的研究证据表明,在乳腺癌、食管癌、肺癌以及结直肠癌等多种肿瘤中存在LINE-1的高表达,提示LINE-1的异常激活与肿瘤发生发展存在密切关联。本文综述了宿主对LINE-1多层次的调控网络,包括表观遗传修饰、非编码RNA以及多种宿主限制因子;探讨了LINE-1在肿瘤微环境中异常激活的分子机制,并总结了LINE-1影响肿瘤发生发展的多种途径,例如影响基因组稳定性、引发炎症和免疫反应以及参与细胞永生化过程。这些研究不仅为LINE-1作为肿瘤分子诊断标志物提供了理论依据,同时为基于LINE-1调控的新型抗肿瘤治疗策略提供了新的视角。

关键词: LINE-1, 逆转录转座子, 肿瘤, 基因组不稳定性, 表观遗传调控 

Abstract:

Transposons, also known as jumping genes, are DNA sequences capable of relocating within or between chromosomes. Long interspersed element-1 (LINE-1), the only autonomously active retrotransposon in the human genome, plays a critical role in maintaining genomic stability through its dynamic regulation. Under normal physiological conditions, the host employs epigenetic and other mechanisms to maintain LINE-1 in a silenced state. However, when this precise regulatory control is disrupted, aberrant LINE-1 activation can lead to insertional mutations, resulting in genomic instability and the development of various genetic disorders and malignant tumors. Recent evidence has demonstrated elevated LINE-1 expression in multiple cancers, such as breast, esophageal, lung, and colorectal cancer, suggesting a close association between LINE-1 dysregulation and tumorigenesis. This review summarizes the multi-layered regulatory network governing LINE-1, encompassing epigenetic modifications, non-coding RNAs, and various host restriction factors. It also explores the molecular mechanisms underlying LINE-1 aberrant activation in the tumor microenvironment and outlines the diverse pathways through which LINE-1 influences tumor development, such as compromising genomic stability, triggering inflammation and immune responses, and participating in cellular immortalization. These findings not only provide a theoretical foundation for utilizing LINE-1 as a molecular biomarker in cancer diagnosis but also offer new perspectives for developing novel anti-tumor therapeutic strategies based on LINE-1 regulation.

Key words: LINE-1, retrotransposons, cancer, genomic instability, epigenetic regulation